Direct reversal of the suppressive function of CD4+ regulatory T cells via tolllike receptor 8 signaling

Details for Australian Patent Application No. 2006223437 (hide)

Owner Baylor College of Medicine

Inventors Peng, Guangyong; Wang, Rong-Fu; Wang, Yicheng

Agent Pizzeys

Pub. Number AU-A-2006223437

PCT Pub. Number WO2006/099021

Priority 60/660,028 09.03.05 US

Filing date 9 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/099021 Priority application(s): WO2006/099021

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223439-Method and apparatus for assigning channels to mesh portals and mesh points of a mesh network

2006223435-Methods and composition related to in vivo imaging of gene expression